Cardiovascular diseases are not only the leading causes of mortality in Bulgaria but also the mortality rate is twice as high as the European Union average, so screening programmes identifying subjects with elevated blood pressure (BP) are of utmost importance. May Measurement Month (MMM) is an annual global initiative of the International Society of hypertension that began in 2017 aimed at raising awareness of high BP. Bulgaria joined the 3rd campaign of MMM in 2019 and an overview of the results of Bulgarian participation are presented in this paper. Hypertension was defined as systolic BP ≥ 140 mm Hg and diastolic BP ≥ 90 mm Hg or treatment for hypertension, statistical analysis followed the standard MMM protocol. In Bulgaria, 150 screening points were set up in primary and secondary care facilities, in pharmacies, and outdoor spaces across 21 administrative districts. Out of 3678 individuals screened, 2587 participants (70.3%) had hypertension. Of 2896 participants with hypertension, 35.6% had controlled BP. Out of 1760 participants not on antihypertensive medication, 669 (38%) had elevated BP. In the case of treated individuals (n = 1918), 997 (52%) had uncontrolled hypertension. In the untreated cohort, every 4th subject had elevated BP, whilst among patients on antihypertensive medication, every second had uncontrolled BP, the worst results in terms of diagnosis and treatment are observed in men. By identifying almost two-third of the whole screened cohort with the possibility of newly diagnosed or uncontrolled hypertension, our results confirm the importance of BP screening campaigns.
Introduction: The EVOLUTION-HF is a prospective, multinational, real-world study designed to describe the demographic and clinical characteristics of patients initiating dapaglifl ozin for heart failure with reduced ejection fraction (HFrEF) in nine countries from the Central and Eastern Europe and Baltic Area. This manuscript presents the results of the Bulgarian cohort of the study. Methods: Enrolment period in Bulgaria was between February 2022 and October 2022, in 10 study sites. Demographic and clinical characteristics were collected at baseline (12 months before dapaglifl ozin initiation), and treatment for heart failure (HF), including guideline-directed treatment (GDMT) was collected prospectively until 12 months after dapaglifl ozin initiation. The HF treatment was administered as per routine clinical practice. Results: One hundred and fi fty patients were included in the full analysis set (mean age: 67 years, males 84%). At the time of initiation of dapaglifl ozin 10 mg/day, 69.3% of patients had treatment with renin-angiotensin-aldosterone system (RAAS) inhibitors and 35.3% all four GDMTs in HF. Almost 98% of patients remained on dapaglifl ozin at 6 months and 12 months. Seven (10.12%) dapaglifl ozin discontinuations were recorded throughout the study. The discontinuation rate of dapaglifl ozin was 4.65 per 100 patient-years and the median time-to-discontinuation was not reached. One patient stopped dapaglifl ozin between baseline and 6 month and between 6 month and 12 month-data collection, respectively. GDMT patterns were relatively stable over one year. Conclusion: A high rate of persistence of dapaglifl ozin was observed at 12-month follow-up after initiation for HFrEF. A substantial gap was noted related to GDMT strategy optimization, with only one third of patients receiving all four GDMT pillars. These results obtained in real-world practice in Bulgaria point to the unmet need for targeted efforts to improve GDMT adoption in patients with HFrEF.
Background: Atrial fibrillation (AF) frequently coexists with heart failure (HF) and worsens clinical outcomes. However, factors associated with AF in HF with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF) remain poorly defined. This study aimed to identify clinical, laboratory, and echocardiographic determinants of AF in these HF phenotypes. Methods: This retrospective single-center observational study included 700 consecutive patients with HF hospitalized between January 2018 and December 2023. The median age was 74 years (IQR 66–80). Women predominated in the cohort (55.3% vs. 44.7%, p < 0.001). Based on echocardiographically assessed left ventricular ejection fraction, patients were stratified into groups with preserved (≥50%), mildly reduced (41–49%), and reduced (≤40%) ejection fraction. Determinants of AF were evaluated using univariate and multivariate logistic regression analyses, and model discrimination was assessed using ROC analysis. Results: Strongest determinants of AF in our patients with HFpEF and HFmrEF were left atrial size (OR 1.114 per mm increase; 95% CI 1.054–1.177; p < 0.001), moderate and severe tricuspid regurgitation (OR 4.092; 95% CI 1.977–8.466; p < 0.001 and OR 6.957; 95% CI 2.482–19.499; p < 0.001), male gender (OR 1.680; 95% CI 1.076–2.621; p = 0.022) and advanced age (OR 1.070 per year; 95% CI 1.032–1.109; p < 0.001). Conclusions: In patients with HFpEF and HFmrEF, AF is strongly associated with atrial remodeling, with left atrial enlargement as the key structural determinant. The identified associations may contribute to an improved understanding of AF in HFpEF and HFmrEF; however, their potential role in risk stratification requires validation in prospective studies.
Background: Atrial fibrillation (AF) frequently coexists with heart failure (HF) and worsens clinical outcomes. However, predictors of AF in HF with preserved (HFpEF) and mildly reduced ejection fraction (HFmrEF) remain poorly defined. This study aimed to identify clinical, laboratory, and echocardiographic predictors of AF in these HF phe-notypes. Methods: This retrospective single-center observational study included 700 consecutive patients with HF hospitalized between January 2018 and December 2023. The median age was 74 years (IQR 66–80). Women predominated in the cohort (55.3% vs. 44.7%, p < 0.001). Based on echocardiographically assessed left ventricular ejection fraction, patients were stratified into groups with preserved (≥50%), mildly reduced (41–49%) and reduced (≤40%) ejection fraction. Predictors of AF were evaluated using univariate and multivariate lo-gistic regression analyses, and model discrimination was assessed using ROC analysis. Results: Strongest predictors of AF in our patients with HFpEF and HFmrEF were left atrial size (OR 1.114 per mm increase; 95% CI 1.054–1.177; p < 0.001), moderate and severe tricuspid regurgitation (OR 4.092; 95% CI 1.977–8.466; p < 0.001 and OR 6.957; 95% CI 2.482–19.499; p < 0.001), male gender (OR 1.680; 95% CI 1.076–2.621; p = 0.022) and advanced age (OR 1.070 per year; 95% CI 1.032–1.109; p < 0.001). Conclusions: In patients with HFpEF and HFmrEF, AF is strongly associated with atrial remodeling, with left atrial enlargement as the key structural predictor. Identification of high-risk patients using clinical and echocardiographic parameters may facilitate earlier AF detection and improved risk stratification.
COVID-19 оказа силен негативен ефект върху системата на здравеопазване в България. Болниците бяха залети с тежки случаи на инфекцията, а в доболничната помощ пациентите се страхуваха да посещават лекарските кабинети. Това доведе до нарастваща обща смъртност и влошен контрол на сърдечно-съдовите заболявания. Проучихме резултатите от годишните прегледи при кардиолог на пациентите с хипертония в една амбулаторна практика в София през 2021 и 2022 г. Резултатите показват силно редуциран брой на посещенията от пациентите през 2021 г. и лош контрол на хипертонията и коморбидностите, продължаващ и през постковидната 2022 г. COVID-19 pandemic affected directly and indirectly the healthcare system in Bulgaria in a very negative manner. The hospitals were flooded with COVID cases and patients were afraid to attend even the outpatient clinics. That resulted in increased mortality and poor control of cardiovascular diseases. We studied the results from the mandatory annual examinations of hypertensive patients in one cardiological outpatient practice in Sofia, Bulgaria in 2021 and 2022. The results showed low level of attendance by the patients in 2021 and poor control of hypertension and comorbidities, that continued even in the post-covid year – 2022.
Индивидуалните стойности на артериалното налягане се доближават до определен популационен модел (поради екологични и социално-икономически фактори), без да го следват напълно (поради специфична индивидуална генетична предразположеност). Тези популационни „модели“ или „траектории“ могат да бъдат проследени до пренаталния период и през целия живот на индивида. Някои от тях са свързани с по-висок риск от развитие на артериална хипертония. Има и няколко ключови (високорискови) моменти в тези модели, при които индивидът може да бъде застрашен от преминаване към група с по-висок сърдечно-съдов риск. Тези траектории на артериалното налягане и високорискови преходни моменти могат да обяснят защо някои хора са по-склонни към увреждане на целевите органи от други. Клиницистите трябва да подхождат индивидуализирано при приложението на насоките на база популационни модели върху конкретен пациент. Правилното дефиниране и практическото познаване на значението на тези траектории на артериалното налягане може да бъде важно за ежедневната профилактика и практика Individual blood pressure values tend to be close to a certain population pattern (because of environmental and socioeconomic factors), without fully following it (because of specifi c individual genetic predisposition). These population “patterns” or “trajectories’ can be followed back to prenatal period and across the whole lifespan. Some of them are correlated with higher risk for development of arterial hypertension. There are also several “cornerstones” in these patterns, where the individual may be at an increased risk for movement to a higher-risk group. They can explain why certain individuals are more prone to target organ damage than others and why we, as clinicians, should have an individualized approach when we translate population-based guidelines to the single patient. Proper defi nition and practical knowledge of the signifi cance of these blood pressure trajectories could be important for everyday prophylaxis and practice.